Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Eichbaum MHR, Kaltwasser M, Bruckner T, De Rossi TM, Schneeweiss A, Sohn C. Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 2006; 96: 53-62. doi: 10.1007/s10549-005-9039-1EichbaumMHRKaltwasserMBrucknerTDe RossiTMSchneeweissASohnCPrognostic factors for patients with liver metastases from breast cancerBreast Cancer Res Treat200696536210.1007/s10549-005-9039-1Open DOISearch in Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7-30. doi: 10.3322/caac.21442SiegelRLMillerKDJemalA.Cancer statistics, 2018CA Cancer J Clin20186873010.3322/caac.21442Open DOISearch in Google Scholar
Ruiz A, Sebagh M, Wicherts DA, Castro-Benitez C, Van Hillegersberg R, Paule B, et al. Long-term survival and cure model following liver resection for breast cancer metastases. Breast Cancer Res and Treat 2018; 170: 89-100. doi: 10.1007/s10549-018-4714-1RuizASebaghMWichertsDACastro-BenitezCVanHillegersberg RPauleBet alLong-term survival and cure model following liver resection for breast cancer metastasesBreast Cancer Res and Treat20181708910010.1007/s10549-018-4714-1Open DOISearch in Google Scholar
Golse N, Adam R. Liver metastases from breast cancer: what role for surgery? Indications and results. Clin Breast Cancer 2017; 17: 256-65. doi: 10.1016/j.clbc.2016.12.012GolseNAdamRLiver metastases from breast cancer: what role for surgery? Indications and resultsClin Breast Cancer2017172566510.1016/j.clbc.2016.12.012Open DOISearch in Google Scholar
Ghersi D, Wilcken N, Simes RJ. A systematic review of taxane-containing regimens for metastatic breast cancer. Br J Cancer 2005; 93: 293-301. doi: 10.1038/sj.bjc.6602680GhersiDWilckenNSimesRJA systematic review of taxane-containing regimens for metastatic breast cancerBr J Cancer20059329330110.1038/sj.bjc.6602680Open DOISearch in Google Scholar
Gordon AC, Uddin OM, Riaz A, Salem R, Lewandowski RJ. Making the case: intra-arterial therapy for less common metastases. Semin Intervent Radiol 2017; 34: 132-9. doi: 10.1055/s-0037-1601852GordonACUddinOMRiazASalemRLewandowskiRJMaking the case: intra-arterial therapy for less common metastasesSemin Intervent Radiol201734132910.1055/s-0037-1601852Open DOISearch in Google Scholar
Smits ML, Prince JF, Rosenbaum CE, van den Hoven AF, Nijsen JF, Zonnenberg BA, et al: Intra-arterial radioembolization of breast cancer liver metastases: a structured review. Eur J Pharmacol 2013; 709: 37-42. doi: 10.1016/j.ejphar.2012.11.067SmitsMLPrinceJFRosenbaumCEvan denHoven AFNijsenJFZonnenbergBAet alIntra-arterial radioembolization of breast cancer liver metastases: a structured reviewEur J Pharmacol2013709374210.1016/j.ejphar.2012.11.067Open DOISearch in Google Scholar
Wang M, Zhang J, Ji S, Shao G, Zhao K, Wang Z, et al. Transarterial chemoembolisation for breast cancer with liver metastasis: a systematic review. Breast 2017; 36: 25-30. doi: 10.1016/j.breast.2017.09.001WangMZhangJJiSShaoGZhaoKWangZet alTransarterial chemoembolisation for breast cancer with liver metastasis: a systematic reviewBreast201736253010.1016/j.breast.2017.09.001Open DOISearch in Google Scholar
Aarts BM, Klompenhouwer EG, Dresen RC, Laenen A, Beets-Tan RGH, Punie K, et al. Intra-arterial mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival. Breast Cancer Res Treat 2019; 176: 597-605. doi: 10.1007/s10549-019-05254-4AartsBMKlompenhouwerEGDresenRCLaenenABeets-TanRGHPunieKet alIntra-arterial mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survivalBreast Cancer Res Treat201917659760510.1007/s10549-019-05254-4Open DOISearch in Google Scholar
Fendler WP, Lechner H, Todica A, Paprottka KJ, Paprottka PM, Jakobs TF, et al. Safety, efficacy and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single center experience in 81 patients. J Nucl Med 2016; 57: 517-23. doi: 10.2967/jnumed.115.165050FendlerWPLechnerHTodicaAPaprottkaKJPaprottkaPMJakobsTFet alSafety, efficacy and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single center experience in 81 patientsJ Nucl Med2016575172310.2967/jnumed.115.165050Open DOISearch in Google Scholar
Pieper CC, Meyer C, Wilhelm KE, Block W, Nadal J, Ahmadzadehfar H, et al. Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases-a single-center experience. J Vasc Interv Radiol 2016; 27: 1305-15. doi: 10.1016/j.jvir.2016.05.028PieperCCMeyerCWilhelmKEBlockWNadalJAhmadzadehfarHet alYttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases-a single-center experienceJ Vasc Interv Radiol20162713051510.1016/j.jvir.2016.05.028Open DOISearch in Google Scholar
Gordon AC, Salem R, Lewandowski RJ. Yttrium-90 radioembolization for breast cancer liver metastases. J Vasc Interv Radiol 2016, 27: 1316-9. doi: 10.1016/j.jvir.2016.06.016GordonACSalemRLewandowskiRJYttrium-90 radioembolization for breast cancer liver metastasesJ Vasc Interv Radiol2016271316910.1016/j.jvir.2016.06.016Open DOISearch in Google Scholar
Maleux G, Deroose C, Laenen A, Verslype C, Heye S, Haustermans K et al. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: technical results, clinical outcome and factors potentially influencing survival. Acta Oncologica 2016; 55: 486-95. doi: 10.3109/0284186X.2015.1101151MaleuxGDerooseCLaenenAVerslypeCHeyeSHaustermansKet alYttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: technical results, clinical outcome and factors potentially influencing survivalActa Oncologica2016554869510.3109/0284186X.2015.1101151Open DOISearch in Google Scholar
Maes T, Wildiers H, Heye S, Demey W, Maleux G, Neven P, et al. Intrahepatic mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer. Breast Cancer Res Treat 2008; 110: 135-42. doi:10.1007/s10549-007-9707-4MaesTWildiersHHeyeSDemeyWMaleuxGNevenPet alIntrahepatic mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancerBreast Cancer Res Treat20081101354210.1007/s10549-007-9707-4Open DOISearch in Google Scholar
Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik F, Sandrasegaran K. Response criteria in oncologic imaging: review of traditional and new criteria. Radiographics 2013; 33: 1323-41. doi: 10.1148/rg.335125214TirkesTHollarMATannMKohliMDAkisikFSandrasegaranKResponse criteria in oncologic imaging: review of traditional and new criteriaRadiographics20133313234110.1148/rg.335125214Open DOISearch in Google Scholar
Pieper CC, Willinek WA, Thomas D, Ahmadzadehfar H, Essler M, Nadal J, et al: Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis. Eur Radiology 2016; 26: 2779-89. doi: 10.1007/s00330-015-4076-6PieperCCWillinekWAThomasDAhmadzadehfarHEsslerMNadalJet alIncidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysisEur Radiology20162627798910.1007/s00330-015-4076-6Open DOISearch in Google Scholar
Collins J, Salem R. Hepatic radioembolization complicated by gastrointestinal ulceration. Semin Intervent Radiol 2011; 28: 240-5. doi: 10.1055/s-0031-1280673CollinsJSalemRHepatic radioembolization complicated by gastrointestinal ulcerationSemin Intervent Radiol201128240510.1055/s-0031-1280673Open DOISearch in Google Scholar
Saxena A, Kapoor J, Meteling B, Morris DL, Bester L. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients. Ann Surg Oncol 2014; 21: 1296-303. doi: 10.1245/s10434-013-3436-1SaxenaAKapoorJMetelingBMorrisDLBesterLYttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patientsAnn Surg Oncol201421129630310.1245/s10434-013-3436-1Open DOISearch in Google Scholar
Bangash AK, Atassi B, Kaklamani V, Rhee TK, Yu M, Lewandowski RJ, et al. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 2007; 18: 621-8. doi: 10.1016/j. jvir.2007.02.019BangashAKAtassiBKaklamaniVRheeTKYuMLewandowskiRJet al90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survivalJ Vasc Interv Radiol200718621810.1016/j.jvir.2007.02.019Open DOISearch in Google Scholar
Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, et al. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 2008; 19: 683-90. doi: 10.1016/j.jvir.2008.01.009JakobsTFHoffmannRTFischerTStemmlerHJTatschKLaFougere Cet alRadioembolization in patients with hepatic metastases from breast cancerJ Vasc Interv Radiol2008196839010.1016/j.jvir.2008.01.009Open DOISearch in Google Scholar
